Application of tRF-Ile-AAT-019 agonist in preparation of medicine for treating psoriasis
A technology of 1.trf-ile-aat-019, 3.trf-ile-aat-019, applied in the application field of preparing medicine for treating psoriasis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0015] The present invention will be further described below in conjunction with the accompanying drawings and embodiments.
[0016] experimental method:
[0017] 1. Human subjects
[0018] This study was approved by the Ethics Committee of the Third Xiangya Hospital of Central South University. All subjects signed written informed consent before participating in the study. The skin biopsy specimens of 21 patients with psoriasis vulgaris confirmed by pathological examination and 21 age- and gender-matched healthy people without personal or family skin history were collected from the Third Xiangya Hospital of Central South University. Both groups had no obvious systemic symptoms (depression, elevated body temperature, vomiting, diarrhea, etc.). We assessed disease severity using the Lesion Area and Severity Index (PASI). The clinical information of all enrolled psoriasis patients is recorded in Table 1. This study was approved by the Human Ethics Committee of the Third Xia...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


